Skip to main content
Skip to footer
Opens in a new tab
Search
Home
About UK NEQAS
Our Team
Sustainability
EQA/PT Programmes
Trial Schedules
Programme Flyers
New Participant Information
Publications
Flow Cytometry Programmes
Molecular Haemato-oncology Programmes
News
FAQs
Contact Us
Home
About UK NEQAS
Our Team
Sustainability
EQA/PT Programmes
Trial Schedules
Programme Flyers
New Participant Information
Publications
Flow Cytometry Programmes
Molecular Haemato-oncology Programmes
News
FAQs
Contact Us
Home
|
Implementation of the updated NICE haematological cancers (NG47) improving outcomes guidelines across Specialist Integrated Haematological Malignancy Diagnostic Services (SIHMDS) in England: a UK NEQAS LI survey
